139 related articles for article (PubMed ID: 17412327)
1. Knockdown of ACAT-1 reduces amyloidogenic processing of APP.
Huttunen HJ; Greco C; Kovacs DM
FEBS Lett; 2007 Apr; 581(8):1688-92. PubMed ID: 17412327
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway.
Huttunen HJ; Peach C; Bhattacharyya R; Barren C; Pettingell W; Hutter-Paier B; Windisch M; Berezovska O; Kovacs DM
FASEB J; 2009 Nov; 23(11):3819-28. PubMed ID: 19625658
[TBL] [Abstract][Full Text] [Related]
3. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease.
Hutter-Paier B; Huttunen HJ; Puglielli L; Eckman CB; Kim DY; Hofmeister A; Moir RD; Domnitz SB; Frosch MP; Windisch M; Kovacs DM
Neuron; 2004 Oct; 44(2):227-38. PubMed ID: 15473963
[TBL] [Abstract][Full Text] [Related]
4. Novel N-terminal cleavage of APP precludes Abeta generation in ACAT-defective AC29 cells.
Huttunen HJ; Puglielli L; Ellis BC; MacKenzie Ingano LA; Kovacs DM
J Mol Neurosci; 2009 Jan; 37(1):6-15. PubMed ID: 18618086
[TBL] [Abstract][Full Text] [Related]
5. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide.
Puglielli L; Konopka G; Pack-Chung E; Ingano LA; Berezovska O; Hyman BT; Chang TY; Tanzi RE; Kovacs DM
Nat Cell Biol; 2001 Oct; 3(10):905-12. PubMed ID: 11584272
[TBL] [Abstract][Full Text] [Related]
6. Role of acyl-coenzyme a: cholesterol acyltransferase activity in the processing of the amyloid precursor protein.
Puglielli L; Ellis BC; Ingano LA; Kovacs DM
J Mol Neurosci; 2004; 24(1):93-6. PubMed ID: 15314256
[TBL] [Abstract][Full Text] [Related]
7. ACAT-selective and nonselective DGAT1 inhibition: adrenocortical effects--a cross-species comparison.
Floettmann JE; Buckett LK; Turnbull AV; Smith T; Hallberg C; Birch A; Lees D; Jones HB
Toxicol Pathol; 2013; 41(7):941-50. PubMed ID: 23427273
[TBL] [Abstract][Full Text] [Related]
8. Acyl-coenzyme A:cholesterol acyltransferase.
Chang TY; Chang CC; Cheng D
Annu Rev Biochem; 1997; 66():613-38. PubMed ID: 9242919
[TBL] [Abstract][Full Text] [Related]
9. Host cell lipids control cholesteryl ester synthesis and storage in intracellular Toxoplasma.
Nishikawa Y; Quittnat F; Stedman TT; Voelker DR; Choi JY; Zahn M; Yang M; Pypaert M; Joiner KA; Coppens I
Cell Microbiol; 2005 Jun; 7(6):849-67. PubMed ID: 15888087
[TBL] [Abstract][Full Text] [Related]
10. Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis.
Chang C; Dong R; Miyazaki A; Sakashita N; Zhang Y; Liu J; Guo M; Li BL; Chang TY
Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):151-6. PubMed ID: 16518538
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of oren-gedoku-to and its components on cholesteryl ester synthesis in cultured human hepatocyte HepG2 cells: evidence from the cultured HepG2 cells and in vitro assay of ACAT.
Yotsumoto H; Yanagita T; Yamamoto K; Ogawa Y; Cha JY; Mori Y
Planta Med; 1997 Apr; 63(2):141-5. PubMed ID: 9140228
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
13. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
Leon C; Hill JS; Wasan KM
Pharm Res; 2005 Oct; 22(10):1578-88. PubMed ID: 16180116
[TBL] [Abstract][Full Text] [Related]
14. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
Burnett JR; Wilcox LJ; Huff MW
Clin Chim Acta; 1999 Aug; 286(1-2):231-42. PubMed ID: 10511295
[TBL] [Abstract][Full Text] [Related]
15. Regulation of acyl coenzyme A:cholesterol acyltransferase in the luteinized rat ovary: observations with an improved enzymatic assay.
Tavani DM; Tanaka T; Strauss JF; Billheimer JT
Endocrinology; 1982 Sep; 111(3):794-800. PubMed ID: 7106051
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of Polygonum cuspidatum water extract (PCWE) and its component resveratrol [correction of rasveratrol] on acyl-coenzyme A-cholesterol acyltransferase activity for cholesteryl ester synthesis in HepG2 cells.
Park CS; Lee YC; Kim JD; Kim HM; Kim CH
Vascul Pharmacol; 2004 Jan; 40(6):279-84. PubMed ID: 15063831
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury.
Kim JH; Ee SM; Jittiwat J; Ong ES; Farooqui AA; Jenner AM; Ong WY
Neuroscience; 2011 Jun; 185():125-34. PubMed ID: 21514367
[TBL] [Abstract][Full Text] [Related]
18. Mammalian acyl-CoA:cholesterol acyltransferases.
Buhman KF; Accad M; Farese RV
Biochim Biophys Acta; 2000 Dec; 1529(1-3):142-54. PubMed ID: 11111084
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of oleate-rich cholesteryl esters by acetyl-LDL in macrophages in the presence of an acyl-CoA: cholesterol acyltransferase inhibitor (Sandoz 58-035).
Shimasaki O; Mineo C; Mowri H; Ohkuma S; Takano T
Biochem Int; 1990; 20(2):389-96. PubMed ID: 2317217
[TBL] [Abstract][Full Text] [Related]
20. ACAT as a drug target for Alzheimer's disease.
Huttunen HJ; Kovacs DM
Neurodegener Dis; 2008; 5(3-4):212-4. PubMed ID: 18322393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
